Headache

Article	Citations
Post‐traumatic headache: An unmet medical need	451
Popping the balloon: Abrupt onset of a spinal CSF leak and spontaneous intracranial hypotension in idiopathic intracranial hypertension, a case report	78
Migraine treatment in pregnancy: A survey of comfort and treatment practices of women's healthcare providers	72
Assessing the influence of migraine on ischemic penumbra and on the prognosis of ischemic stroke: A prospective cohort study	67
Drug‐resistant epicrania fugax: Responding to onabotulinumtoxinA	65
A retrospective cohort study of clinical factors, visit patterns, and demographic factors associated with use of remote communications in patients with headache	64
Erratum	60
Persistence, effectiveness, and tolerability of anti‐calcitonin gene–related peptide monoclonal antibodies in patients with chronic migraine	57
Characteristics associated with response to subcutaneously administered anti‐CGRP monoclonal antibody medications in a real‐world community cohort of persons living with migraine: A retrospective clin	53
Effect of caffeine and caffeine cessation on cerebrovascular reactivity in patients with migraine	51
Facial variant of epicrania fugax secondary to a cerebellopontine angle meningioma	50
Migraine screening in English and Spanish	46
The impacts of migraine on functioning: Results from two qualitative studies of people living with migraine	42
Pilot study evaluating treatment with sumatriptan for moderate to severe post‐traumatic headache: A phase 2 open‐label study	42
Normal glymphatic system function in patients with new daily persistent headache using diffusion tensor image analysis along the perivascular space	42
Anxiety, depression, and headache‐related disability in a large pediatric clinic–based sample	38
Improvements in quality of life and work productivity with up to 6 months of fremanezumab treatment in patients with episodic and chronic migraine and documented inadequate response to 2 to 4 classes	35
Migraine and peripheral pain models show differential alterations in neuronal complexity	34
A retrospective analysis of the use of candesartan for migraine prevention in adolescents	33
Clinical characteristics and perfusion‐computed tomography alterations in a series of patients with migraine with aura attended as stroke code	32
Adaptation of the management of chronic migraine patients with medication overuse to the suspension of treatment protocols during the COVID‐19 pandemic: Lessons from a tertiary headache center in Mila	31
Headache and psychological variables as predictors of disability in individuals with primary headache disorders	30
Developing and delivering a migraine disparities and diagnosis undergraduate medical educational program to underrepresented in medicine medical student members of the Student National Medical Associa	29
Long‐term efficacy and safety of erenumab in patients with chronic migraine and acute medication overuse: A subgroup analysis	28
CCH attack frequency reduction after psilocybin correlates with hypothalamic functional connectivity	27

Telehealth as a new care delivery model: The headache provider experience	27
Skin wetness sensitivity across body sites commonly affected by pain in people with migraine	27
Patient preference for early onset of efficacy of preventive migraine treatments	26
Patient‐reported experiences with migraine‐related cognitive symptoms: Results of the MiCOAS qualitative study	25
Prevalence of primary stabbing headache: A meta‐analysis	25
Sex and gender: Opportunities to expand research and understanding within headache medicine	24
Sequential administration of peripheral nerve blocks and onabotulinumtoxinA for the treatment of chronic migraine and other headache disorders—A retrospective tolerability and safety study	23
The teaching of headache medicine in France: A questionnaire‐based study	23
A retrospective review of sex differences of white matter hyperintensities in brain MRI of patients with migraine	23
Effects of fremanezumab on migraine‐associated symptoms and medication use in Japanese and Korean patients with episodic migraine: Exploratory endpoint analysis of a multicenter, randomized, double‐bl	23
Patient headache questionnaires can improve headache diagnosis and treatment in children	23
Neuromodulation for primary headache disorders: Advantages and challenges	22
Crystal‐clear days and unclear days in migraine: A population‐based study	22
Effect of erenumab versus other migraine preventive medications on cardiovascular and cerebrovascular outcomes: A United States claims database‐based observational cohort study	22
Issue Information	21
Efficacy of a pediatric headache infusion center: A single‐center experience	21
Recurrent painful ophthalmoplegic neuropathy with headache and oculomotor palsy 18 years apart	21
Headache and acute cerebrovascular disease: How do we differentiate primary and secondary headache disorders in the emergency setting?	21
Post‐vaccination headache reporting: Trends according to the Vaccine Adverse Events Reporting System	20
Alcohol as a trigger of migraine attacks in people with migraine. Results from a large prospective cohort study in English‐speaking countries	20
Evaluation of vascular risk in patients with migraine with and without aura treated with erenumab: Post hoc analysis of pooled long‐term clinical trial data	20
	20
Changes in cognitive appraisal in a randomized controlled trial of mindfulness‐based cognitive therapy for patients with migraine	20
Socioeconomic and geographic inequalities in headache disability in Brazil: The 2019 National Health Survey	20
Prevalence, characteristics, and factors associated with caffeine‐withdrawal headache during the first day of Ramadan	19
Protracted headache after COVID‐19: A case series of 31 patients from a tertiary headache center	19
Sustained benefits of onabotulinumtoxinA treatment in chronic migraine: An analysis of the pooled Phase 3 REsearch Evaluating Migraine Prophylaxis Therapy (PREEMPT) randomized controlled trials	19
Issue Information	19
Assessing blood pressure changes and hypertension‐related outcomes in patients with migraine treated with erenumab: A systematic review and meta‐analysis	19
Dystonia phenomenology and treatment response in migraine	18
Challenges and opportunities for estimating and assessing migraine prevalence, incidence and impact across study populations and methodologies: Bridging global and United States findings	18
The elephant in the room: How the underfunding of headache research stunts the field	18
OnabotulinumtoxinA as a promising treatment for primary trochlear headache: A retrospective case series	18
A large language model–based generative natural language processing framework fine‐tuned on clinical notes accurately extracts headache frequency from electronic health records	17
The usefulness of osmophobia for the diagnosis of migraine in children and adolescents	17
The 2024 Headache editorial board Conflict of Interest Declarations	17
Neck pain associated with migraine does not necessarily reflect cervical musculoskeletal dysfunction	17
Remote electrical neuromodulation to treat children and adolescents with migraine in the emergency department: A randomized double‐dummy pilot trial	17
	16
Melatonin for migraine prevention in children and adolescents: A randomized, double‐blind, placebo‐controlled trial after single‐blind placebo lead‐in	16
Arachnoiditis following epidural blood patch—An avoidable rare complication due to blind technique: A response	16
	16
Issue Information	16
Eicosapentaenoic acid versus placebo as adjunctive therapy in chronic migraine: A randomized controlled trial	16
Clinical factors associated with day‐to‐day peak pain severity in individuals with chronic migraine: A cohort study using daily prospective diary data	16
Prediction of individual trigeminal pain sensitivity from gray matter structure within the sensorimotor network	16
Essential components of care in a multidisciplinary headache center: Perspectives from headache neurology specialists	15
Emergency department utilization among patients who receive outpatient specialty care for headache: A retrospective cohort study analysis	15
Challenges in the management of new daily persistent headache at a tertiary headache center—A retrospective real‐world evidence study	15
Red flags in headache care	15

The cortical spreading depression/migraine aura hypothesis – Finally some definitive evidence	15
Effect of galcanezumab in women with episodic migraine meeting criteria for menstrually related migraine: A post hoc analysis of EVOLVE‐1 and EVOLVE‐2	15
Burden of migraine in Brazil: A cross‐sectional real‐world study	15
Development and pharmacological characterization of novel multi‐ calcitonin gene‐related peptide and pituitary adenylate cyclase‐activating peptide receptor antagonists	15
Issue Information	14
Decision‐making impairment under ambiguity but not under risk may underlie medication overuse in patients with chronic migraine	14
The current state of headache medicine education in the United States and Canada: An observational, survey‐based study of neurology clerkship directors and curriculum deans	14
Different dosage regimens of erenumab for the treatment of migraine: A systematic review and meta‐analysis of the efficacy and safety of randomized controlled trials	14
Timing and durability of response to erenumab in patients with chronic migraine	14
Afterimage duration differs for migraine with or without aura	14
	14
Effect of wildfire smoke on primary headache disorders remains unclear	13
Essential but often overlooked reporting elements for Headache manuscripts	13
Long‐term effectiveness of eptinezumab in the treatment of patients with chronic migraine and medication‐overuse headache	13
A man with tongue pain: A case study	13
Plain Language Summary Publication: The 2023 protocol for update to acute treatment of adults with migraine in the emergency department: The American headache society evidence assessment of parenteral	13
Arachnoid granulations in idiopathic intracranial hypertension: Do they have an influence?	13
Patient‐identified most bothersome symptom in preventive migraine treatment with eptinezumab: A novel patient‐centered outcome	13
Intracranial hypotension as a contributor to isolated cortical vein thrombosis	12
Headache in transgender men using gender‐affirming hormone therapy: A case–control study	12
Are psychological interventions efficacious for adults with migraine? A systematic review and meta‐analysis	12
Characterization of trigeminal C‐fiber reactivity through capsaicin‐induced release of calcitonin gene‐related peptide	12
Zavegepant nasal spray for the acute treatment of migraine: A Phase 2/3 double‐blind, randomized, placebo‐controlled, dose‐ranging trial	12
Beyond aura: Understanding migraine as a cycling pan‐sensory threshold disease	12
Comparison and predictors of chronic migraine vs. new daily persistent headache presenting with a chronic migraine phenotype	12
Clinical characteristics and patient‐reported outcomes of chronic and episodic migraine patients at a US tertiary headache center: A retrospective observational study	12
Digital headache self‐management interventions for patients with a primary headache disorder: A systematic review of randomized controlled trials	12
Plasma calcitonin gene–related peptide and nerve growth factor as headache and pain biomarkers in recently deployed soldiers with and without a recent concussion	12
Reducing the physical, social, and emotional impact of episodic migraine: Results from erenumab STRIVE and ARISE phase III randomized trials	12
Secondary nummular headache: Are they more common than we thought?	12
American Headache Society 64th Annual Scientific Meeting June 9–12, 2022 Denver, Colorado	12
The American Headache Society Consensus Statement: Update on integrating new migraine treatments into clinical practice	12
Validity of self‐reported migraine in adolescents and children	11
Improving distress perception and mutuality in migraine caregivers after 6 months of galcanezumab treatment	11
	11
Headache attributed to idiopathic intracranial hypertension and persistent post‐idiopathic intracranial hypertension headache: A narrative review	11
Migraine and infertility, merging concepts in women's reproductive health: A narrative review	11
The link between reversible cerebral vasoconstriction syndrome and transient global amnesia	11
Glial activation in pain and emotional processing regions in the nitroglycerin mouse model of chronic migraine	11
Visual hypersensitivity in patients treated with anti‐calcitonin gene–related peptide (receptor) monoclonal antibodies	11
Post hoc analysis of clinical trial data and pharmacokinetic data to assess wearing‐off of erenumab within monthly treatment cycle	11
Plain Language Summary Publication: Evaluating the use of paracetamol to prevent fasting headache during the first week of Ramadan: A randomized, open‐label, clinical trial	11
Beyond movement: Headache in patients with functional movement disorders	11
Migraine epidemiology in collegiate student‐athletes: Findings from the Concussion Assessment, Research, and Education (CARE) Consortium	11
Clinical features, disease progression, and use of healthcare resources in a large sample of 866 patients from 24 headache centers: A real‐life perspective from the Italian chROnic migraiNe (IRON) pro	11
Issue Information	11
A randomized trial of ketorolac and metoclopramide for migraine in the emergency department	10
Migraine in the context of chronic primary pain, chronic overlapping pain disorders, and functional somatic disorders: A narrative review	10
Mechanisms of change in posttraumatic headache–related disability: A mediation model	10
Celebrating Headache's 2023 graduating class of Assistant Editors	10
Exploring the impact of acute SARS‐CoV‐2 infection on headache pattern in patients with migraine: A novel Bayesian analysis	10
Development and validation of a novel patient‐reported outcome measure in people with episodic migraine and chronic migraine: The Activity Impairment in Migraine Diary	10
The impact of updates in headache quality measures on adherence to best practices in a neurology resident clinic: A quality improvement study	10
The pathogenic role of calcitonin gene‐related peptide and predictors of new‐onset migraine and long‐term outcomes after transcatheter atrial septal defect closure	10
	10
Cluster Analysis of Migraine‐associated Symptoms (CAMS) in youth: A retrospective cross‐sectional multicenter study	10
Time to reconsider the association between migraine and white matter hyperintensities?	10
Blink reflex: A practical test to evaluate the trigeminal nerve injury following percutaneous balloon compression for the treatment of trigeminal neuralgia	10
Magnetoencephalography studies in migraine and headache disorders: A systematic review	10
Circadian functional changes of pain‐processing brainstem nuclei and implications for cluster headache: A 7 Tesla imaging study	10
The importance of patient and family perspectives of clinical decisions in pediatric headache	9
Cerebrovascular reactivity to hypercapnia in patients with migraine: A dual‐echo arterial spin labeling MRI study	9
A critical appraisal of the International Classification of Headache Disorders migraine diagnostic criteria based on a retrospective multicenter cross‐sectional headache registry study in youth	9
The Chronic Headache Self‐Efficacy Scale: Development and assessment of measurement properties	9
Headache diagnosis and treatment: A pilot knowledge and needs assessment among physical therapists	9
Role of memantine in the prophylactic treatment of episodic migraine: A systematic review	9
Counting the cost: How migraine shapes lives and economies	9
Symptomatic visual snow in acute ischemic stroke: A case series	9
Issue Information	9
	9
A post hoc analysis of migraine‐associated symptoms from the phase 3 randomized, double‐blind, sham‐controlled Trial of External trigeminal nerve stimulation for the Acute treatment of Migraine (	9
Patient headache questionnaires can improve headache diagnosis and treatment in children	9
Heavy metal and trace element alterations in patients during a migraine attack	9
The effectiveness of parenteral agents for pain reduction in patients with migraine presenting to emergency settings: A systematic review and network analysis	9
Continuous updating of individual headache forecasting models using Bayesian methods	8
Long‐term (48 weeks) effectiveness, safety, and tolerability of erenumab in the prevention of high‐frequency episodic and chronic migraine in a real world: Results of the EARLY 2 study	8
	8
Efficacy of an educational website on headaches in schoolchildren: A cluster‐randomized controlled trial	8
Exploratory investigation of a patient‐informed low‐dose psilocybin pulse regimen in the suppression of cluster headache: Results from a randomized, double‐blind, placebo‐controlled trial	8
Indomethacin‐responsive idiopathic red ear syndrome: A pediatric case	8

Author Index	8
Secondary cluster headache due to a contralateral demyelinating periaqueductal gray matter lesion	8
Osmophobia in children with headaches: A need for further studies	8
Migraine, idiopathic intracranial hypertension, and calcitonin gene‐related peptide antibodies	8
	8
Heightened migraine risk in patients with rheumatoid arthritis: A national retrospective cohort study	8
Insight of a headache medicine provider in Indian Health Service: A personal and professional observation	7
Welcoming Headache's 2024 incoming class of Assistant Editors	7
Healthcare costs and resource utilization in patients with migraine treated with erenumab: A retrospective, non‐interventional study using claims data from the United States	7
Twenty twenty … two: Headache and COVID‐19	7
Issue Information	7
Headache basic science prize	7
Correction to “A causative role for remote dural puncture and resultant arachnoid bleb in new daily persistent headache: A case report”	7
Investigating the effects of weather on headache occurrence using a smartphone application and artificial intelligence: A retrospective observational cross‐sectional study	7
Preliminary exploration of a multidimensional sleep health composite in adolescent females with frequent migraine	7
Trainee highlights	7
Neuropathic changes in corneal nerve endings—A potential objective biomarker for migraine frequency and response to treatment	7
AHS 2021 consensus on integrating new migraine therapies into clinical practice: Isn’t our goal choice of best therapy regardless of cost?	7
The impact of a digital platform on migraine patient‐centered outcome research. Evaluation of midolordecabeza.org, a headache website in Spanish	7
A placebo controlled, randomized clinical trial of galcanezumab for vestibular migraine: The INVESTMENT study	7
Structural aberrations of the brain associated with migraine: A narrative review	7
Different characteristics of cortical spreading depression in the sleep and wake states	7
The impact of fear of attacks on pain‐related disability in cluster headache: Insights from the fear avoidance model	7
Comparative prevalence and characteristics of fabricated citations in large language models in headache medicine	7
Diagnostic accuracy of an artificial intelligence online engine in migraine: A multi‐center study	7
Virtual issue: Recent advances in pediatric headache: Bridging the data gap	7
The 15‐day threshold in the definition of chronic migraine is reasonable and sufficient—Five reasons for not changing the ICHD‐3 definition	7
Good News? Bad News? Idiopathic intracranial hypertension and migraine	7
Machine learning models and classification algorithms in the diagnosis of vestibular migraine: A systematic review and meta‐analysis	7
Intranasal treatment of cluster headache: A response	7
Nerve block as neuropathic pain treatment for the great auricular nerve neuropathy: A case report	7
	7
Sustained response of galcanezumab in migraine prevention: Patient‐level data from a post hoc analysis in patients with episodic or chronic migraine	6
Perceived stress and pain severity in individuals with chronic migraine: A longitudinal cohort study using daily prospective diary data	6
Asking the right questions: The value of headache specialty care	6
New insight into the neural mechanisms of migraine in adolescents: Relationships with sleep	6
Advancing our commitment to our peer reviewers	6
Challenges and complexities in designing cluster headache prevention clinical trials: A narrative review	6
Management and outcomes of persistent headache after accidental dural puncture in the obstetric population: A 9‐year prospective audit	6
Multi‐region local field potential signatures and brain coherence alternations in response to nitroglycerin‐induced migraine attacks	6
A multicenter, randomized, double‐blind, placebo‐controlled, crossover trial to evaluate the efficacy and safety of zolmitriptan nasal spray for the acute treatment of migraine in patients aged 6 to 1	6
Cost per treatment responder analysis of atogepant compared to rimegepant for the preventive treatment of episodic migraine	6
Trainee highlights	6
Blood serum levels of PACAP and migraine onset: A systematic review and meta‐analysis of observational studies	6
Headache neuroimaging: A survey of current practice, barriers, and facilitators to optimal use	6
Issue Information	6
Development and initial validation of the Kiswahili version of the Migraine Disability Assessment (MIDAS‐K) questionnaire	6
Learning headache triggers through experience: A laboratory study	6
Epidemiology, investigation, management, and outcome of headache in emergency departments (HEAD study)—A multinational observational study	6
Headache launches the publication of plain language summaries	6
Habitual caffeinated beverage consumption and headaches among adults with episodic migraine: A prospective cohort study	6
A multidirectional approach to osmophobia symptoms	6
Plain Language Summary Publication: Regulation of headache response and transcriptomic network by the trigeminal ganglion clock	6
Real world evidence of changes in CGRP monoclonal antibody and onabotulinumtoxinA prescription practices at the start of the COVID‐19 pandemic: An observational, retro	6
	6
The complex relationship between alcohol and migraine	6
Lacosamide for refractory trigeminal neuralgia and other facial pain—Case report	6
Changes in migraine characteristics over 30 days of Ramadan fasting: A prospective study	6
Alterations in the structure and function of the brain in adolescents with new daily persistent headache: A pilot MRI study	6